Unmet Treatment Requirements Will Encourage Growth in the HER-2 Positive Breast Cancer Market in US through 2019: TechNavio
London, 17 March 2015 – Pressing unmet medical needs have resulted in the growth of the HER-2 Positive Breast Cancer Market in the US, which is expected to post a CAGR of 12.65 percent from 2014-2019, says research firm TechNavio. About the Report According to the latest report by TechNavio, the current treatment options…
